|
13 Apr 2025 |
Cyient
|
Consensus Share Price Target
|
1144.20 |
1608.13 |
- |
40.55 |
hold
|
|
|
|
|
24 Jan 2025
|
Cyient
|
IDBI Capital
|
1144.20
|
1675.00
|
1344.90
(-14.92%)
|
46.39 |
Hold
|
|
|
|
|
23 Jan 2025
|
Cyient
|
Motilal Oswal
|
1144.20
|
1350.00
|
1755.25
(-34.81%)
|
Target met |
Sell
|
|
|
DET business reported 3QFY25 revenues of USD175m, up 2.4% QoQ in CC vs. our estimate of 2.3% growth. Cyient reported broad-based growth in revenues across verticals, except Sustainability (down 1.3% QoQ cc).
|
|
23 Jan 2025
|
Cyient
|
Emkay
|
1144.20
|
1700.00
|
1755.30
(-34.81%)
|
Target met |
Sell
|
|
|
Cyient posted inline revenue performance in DET in Q3, while EBITM missed estimates. DET revenue grew 1.3% QoQ (2.4% CC) to USD175.2mn. DET EBITM declined by 70bps QoQ to 13.5%, coming in below our estimate.
|
|
22 Nov 2024
|
Cyient
|
Geojit BNP Paribas
|
1144.20
|
2066.00
|
1802.50
(-36.52%)
|
Target met |
Accumulate
|
|
|
|
|
30 Oct 2024
|
Cyient
|
Anand Rathi
|
1144.20
|
2230.00
|
1830.80
(-37.50%)
|
94.90 |
Buy
|
|
|
With 2% q/q growth (1.3% in CC),aided by broad-based growth across verticals, Cyient’s Q2 was in line with estimates. Sustainability, however, declined a steep 6.4% sequentially (-2.2% y/y) in CC.
|
|
25 Oct 2024
|
Cyient
|
Axis Direct
|
1144.20
|
1900.00
|
1798.10
(-36.37%)
|
Target met |
Hold
|
|
|
With limited growth potential due to first-quarter impact, we recommend a HOLD recommendation on the stock.
|
|
25 Oct 2024
|
Cyient
|
IDBI Capital
|
1144.20
|
2018.00
|
1798.10
(-36.37%)
|
Target met |
Hold
|
|
|
|
|
24 Oct 2024
|
Cyient
|
Motilal Oswal
|
1144.20
|
2100.00
|
1777.55
(-35.63%)
|
Target met |
Buy
|
|
|
DET business reported 2QFY25 revenues of USD173m, up 1.3% QoQ in CC vs. our estimate of 1.0% growth. Cyient reported broad-based growth in revenues across verticals, except Sustainability (down 6.45 QoQ cc).
|
|
14 Aug 2024
|
Cyient
|
Geojit BNP Paribas
|
1144.20
|
1922.00
|
1734.90
(-34.05%)
|
Target met |
Accumulate
|
|
|
|
|
26 Jul 2024
|
Cyient
|
Axis Direct
|
1144.20
|
2000.00
|
1789.90
(-36.07%)
|
Target met |
Hold
|
|
|
With limited growth potential due to first quarter impact, we recommend HOLD recommendation on the stock.
|
|
25 Jul 2024
|
Cyient
|
Motilal Oswal
|
1144.20
|
2070.00
|
1894.20
(-39.59%)
|
Target met |
Buy
|
|
|
CYL reported a broad-based decline in revenues across verticals in 1QFY25. DET business revenue declined 5.0% QoQ in CC vs. our estimate of a 1.5% fall.
|
|
10 May 2024
|
Cyient
|
Geojit BNP Paribas
|
1144.20
|
1972.00
|
1721.65
(-33.54%)
|
Target met |
Accumulate
|
|
|
|
|
26 Apr 2024
|
Cyient
|
Axis Direct
|
1144.20
|
2500.00
|
1885.80
(-39.33%)
|
118.49 |
Buy
|
|
|
With strong growth potential backed by robust deal wins and superior execution capabilities, we maintain our BUY recommendation on the stock.
|
|
26 Apr 2024
|
Cyient
|
Emkay
|
1144.20
|
2600.00
|
1885.80
(-39.33%)
|
127.23 |
Buy
|
|
|
Cyient reported a weak operating performance in Q4FY24. DET revenue grew 0.1% QoQ (decline of 0.5% cc), falling short of our estimate of 1.4% QoQ growth.
|
|
26 Apr 2024
|
Cyient
|
IDBI Capital
|
1144.20
|
2210.00
|
1885.80
(-39.33%)
|
93.15 |
Buy
|
|
|
|
|
10 Feb 2024
|
Cyient
|
Axis Direct
|
1144.20
|
2460.00
|
2192.25
(-47.81%)
|
|
Buy
|
|
|
We recommend a BUY rating on the stock with a near term TP of Rs 2460, implying an upside of 12% from CMP.
|
|
05 Feb 2024
|
Cyient
|
Geojit BNP Paribas
|
1144.20
|
2447.00
|
2169.45
(-47.26%)
|
|
Accumulate
|
|
|
|
|
29 Jan 2024
|
Cyient
|
Axis Direct
|
1144.20
|
3000.00
|
2006.45
(-42.97%)
|
|
Buy
|
|
|
With strong growth potential backed by robust deal wins and superior execution capabilities, we maintain our BUY recommendation on the stock.
|
|
28 Jan 2024
|
Cyient
|
IDBI Capital
|
1144.20
|
2360.00
|
2019.65
(-43.35%)
|
|
Buy
|
|
|
|
|
11 Dec 2023
|
Cyient
|
Axis Direct
|
1144.20
|
2195.00
|
2003.45
(-42.89%)
|
Target met |
Buy
|
|
|
We recommend a BUY rating on the stock and assign a 22x P/E multiple to its FY26E earnings of Rs 99.4/share to arrive at a TP of Rs 2,195/share, implying an upside of 13% from the CMP.
|